China close to entering WHO-approved global vaccine market


China close to entering WHO-approved global vaccine market
A Chinese-made vaccine is on the verge of being approved for aid agency use by the World Health Organization, a move that would be a first for China and open the door to lucrative regional and global markets, a leading health alliance said on Thursday.

The vaccine is against Japanese encephalitis, a debilitating mosquito-borne disease prevalent in Southeast Asia and the Far East that can be fatal, especially in children.

Made by Chengdu Institute, part of China’s top vaccine maker China National Biotech Group (CNBG), the vaccine is likely to win so-called prequalification status from the World Health Organization (WHO), Seth Berkley, chief executive of the Global Alliance for Vaccines and Immunization (GAVI), said…